Clinical Trials Browser

Breast Neoplasms

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

Neurofibroma, Neurofibromatosis 1

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Adenomatous Polyposis Coli, Colorectal Neoplasms

Colorectal Neoplasms

Lymphangioleiomyomatosis

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Adenomatous Polyposis Coli, Colorectal Neoplasms

Peritoneal Neoplasms

Breast Neoplasms

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Prostatic Neoplasms

Colorectal Neoplasms

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Breast Neoplasms

Smoking, Tobacco Use Disorder

Precancerous Conditions

Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms

Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Head and Neck Neoplasms, Stomatitis, Mucositis

Head and Neck Neoplasms, Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Brain Neoplasms, Glioblastoma

Clinical Trials

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Medical Treatment of "High-Risk" Neurofibromas

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

COLA

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

REACT

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

UAB0040

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Cox-2 Inhibition in Radiation-induced Oral Mucositis

RAD0201

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients